P
Per Venge
Researcher at Uppsala University
Publications - 457
Citations - 34544
Per Venge is an academic researcher from Uppsala University. The author has contributed to research in topics: Eosinophil cationic protein & Eosinophil. The author has an hindex of 86, co-authored 454 publications receiving 33109 citations. Previous affiliations of Per Venge include University of Helsinki & Karolinska Institutet.
Papers
More filters
Journal ArticleDOI
Blood eosinophils and eosinophil cationic protein after acute myocardial infarction or corticosteroid administration.
TL;DR: The results suggest that ECP is released from eosinophils in vivo, and the raised levels of S‐ECP in patients with acute myocardial infarction are probably due to the active participation of eosInophil in the inflammatory process.
Journal ArticleDOI
Bronchial mucosal mast cells in asymptomatic smokers relation to structure, lung function and emphysema
A Ekberg-Jansson,Kawa Amin,Björn Bake,Annika Rosengren,Ulf Tylen,Per Venge,Claes-Göran Löfdahl +6 more
TL;DR: Smoking is associated with an increase of mast cells in all compartments of the bronchial mucosa, including smooth muscle, and this is related to altered airway structure and function.
Journal Article
Eosinophil involvement in rheumatoid arthritis as reflected by elevated serum levels of eosinophil cationic protein.
TL;DR: Although eosinophils are not a notable feature of the synovial membrane infiltrate or cellular joint exudate, data obtained indirectly indicates their participation in the inflammatory reaction in RA.
Journal ArticleDOI
Interleukin-17A mRNA and protein expression within cells from the human bronchoalveolar space after exposure to organic dust.
TL;DR: Exposure to organic dust increases local IL-17A mRNA and because there is intracellular expression in BAL lymphocytes, this suggests that IL- 17A protein can originate from lymphocytes within the human bronchoalveolar space through its neutrophil-accumulating effect.
Journal ArticleDOI
Troponin-Specific Autoantibody Interference in Different Cardiac Troponin I Assay Configurations
Tanja Savukoski,Emilia Engström,Janne Engblom,Noora Ristiniemi,Saara Wittfooth,Bertil Lindahl,Kai M. Eggers,Per Venge,Kim Pettersson +8 more
TL;DR: A novel cTnI assay deviating from the conventional IFCC-recommended midfragment approach substantially improves cTNI detection in samples containing cTtnAAb and confirms the reduced concentrations expected from the low analytical recoveries.